October

October 20, 2014

Vitamin-based life-extention therapy for Males: ATRA (a derivative of Vitamin-A) increases male longevity via up regulation of its target gene, 20/October/2014, 6.08 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, L., Vitamin-based life-extention therapy for Males: ATRA (a derivative of Vitamin-A) increases male longevity via up regulation of […]
October 20, 2014

Physiological and Pathological mechanisms that control glycolysis: NR2F2 inhibits glycolysis and cancer progression via down regulation of PDK1, 20/October/2014, 6.03 am

A recent study from the Institute for Cancer Research and CAS Key Laboratory of Innate Immunity and Chronic Disease, Innovation Center for Cell Biology, School of Life Science, University […]
October 19, 2014

Interleukin-based therapy for Metabolic disorders: Lin-28 increases insulin sensitivity, restores mucosal immunity and decreases endotoxaemia via up regulation of Interleukin-22, 19/October/2014, 21.57

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Interleukin-based therapy for Metabolic disorders: Lin-28 increases insulin sensitivity, restores mucosal immunity and decreases […]
October 19, 2014

Treating Alzhemer’s disease with an NIDDM drug: Metformin, the widely used drug in the treatment of T2DM, decreases Tau expression via up regulation of its target gene, 19/October/2014, 21.54

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, L. Treating Alzhemer’s disease  with an NIDDM drug: Metformin, the widely used drug in the treatment of […]